Drugs / Ragweed-SPIRE
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02061670 | Jan → Oct 2014 | asthma, seasonal allergic rhinitis | Circassia Limited | Completed | No outcome recorded |
| Phase 2 | NCT02061709 | Jan → Oct 2014 | seasonal allergic rhinitis | Circassia Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ragweed-SPIRE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02061709 ↗ |